Companies: 10,795·Total market cap: $144.5T

Nanobiotix S.A.

Nanobiotix S.A.

NBTXNASDAQHealthcare● Active

$36.47

+$1.01(+2.85%)

Market Cap$1.8B

P/E Ratio—

52W High$57.14

52W Low$4.18

Avg Volume77K

Open$35.13

Beta0.59

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Nanobiotix S.A.（NBTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NBTX · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.94Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$22.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding47.8MShares outstanding history

Next EarningsSep 30, 2026Est.Earnings history

探索 Nanobiotix S.A. 数据

分析师预测$38 · Buy

股息不分红

营收$29.6M+512.28%

盈利EPS $-0.50+65.28%

财务快照

FY 2025Revenue$29.6M▲ +512.28% YoY

202320242025

FY 2025Net Income-$24.0M▲ +64.83% YoY

202320242025

FY 2025EPS$-0.50▲ +65.28% YoY

202320242025

TTM:Revenue: $22.5MNet Income: -$92.1MEPS: $-1.94View income statement →

分析师评级与目标价

Buy4 位分析师

Strong Buy

0

Buy

3

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$30.00Low

$36.47Current

$38.00Avg Target上涨空间 4.20%

$46.00High

合计: 4 · 买入占比: 75.0%

根据过去 3 个月内 4 位华尔街分析师，NBTX 共识评级为 Buy，12 个月平均目标价 $38.00 （较现价 $36.47 上涨空间 4.20%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Nanobiotix S.A.

$36.47+2.85%$1.8B #2

Arbutus Biopharma Corporation

$4.22-0.94%$833.6M #3

EyePoint Pharmaceuticals, Inc.

$11.42-2.80%$957.4M #4

GH Research PLC

$20.46-5.13%$1.4B #5

Kura Oncology, Inc.

$8.58-1.72%$761.2M #6

LENZ Therapeutics, Inc.

$6.72-3.72%$210.7M

股票表现

1D-0.72%

1W-0.72%

1M-22.61%

3M+3.57%

YTD+52.27%

1Y+652.24%

5Y+104.68%

关于 Nanobiotix S.A.

CEOLaurent Levy

IPO DateDec 11, 2020

Employees108

CountryFR

Websitenanobiotix.com

Nanobiotix S.A. a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline…

Biotechnology HealthcareNASDAQADRFR

关于股票概览与关键数据

Nanobiotix S.A.（NBTX）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 11, 2020 在 NASDAQ 上市。截至最近交易日，NBTX 股价为 $36.47，市值约为 $1.8B。过去12个月累计回报 +652.24%，年初至今回报 +52.27%。

根据 4 位华尔街分析师，Nanobiotix S.A. 股票共识评级为Buy，12个月平均目标价为 $38.00。2025 财年 Nanobiotix S.A. 营收 $29.6M，净利润 -$24.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Nanobiotix S.A.（NBTX）股价为 $36.47，在 NASDAQ 上市，52周区间为 $4.18 – $57.14。

NBTX 最新股价NBTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议